MedTrace Logo

Pazufloxacin Mesilate Ear Drops Clinical Trial Protocol

NCT02592096 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2015-10-30

No results posted yet for this study

Summary

To investigate the safety, tolerance, dynamic percolation model of single dose usage pazufloxacin mesilate ear drops for patients with acute suppurative otitis media or chronic suppurative otitis media

Conditions

  • Otitis Media

Interventions

DRUG

0.1% Pazufloxacin Mesilate Ear Drops

DRUG

0.3% Pazufloxacin Mesilate Ear Drops

DRUG

0.5% Pazufloxacin Mesilate Ear Drops

DRUG

Pazufloxacin mesilate injection

Sponsors & Collaborators

  • Lee's Pharmaceutical Limited

    lead INDUSTRY

Principal Investigators

  • Weiguo Cue, MD · Qingdao Municipal Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-01-31
Completion
2016-02-29

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02592096 on ClinicalTrials.gov